nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—prostate cancer	0.199	1	CbGaD
Imiquimod—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0565	0.138	CbGbCtD
Imiquimod—CYP1A2—Flutamide—prostate cancer	0.047	0.115	CbGbCtD
Imiquimod—CYP1A2—Estrone—prostate cancer	0.034	0.0831	CbGbCtD
Imiquimod—CYP3A4—Bicalutamide—prostate cancer	0.0297	0.0726	CbGbCtD
Imiquimod—CYP3A4—Estramustine—prostate cancer	0.0276	0.0675	CbGbCtD
Imiquimod—CYP3A4—Flutamide—prostate cancer	0.0246	0.0602	CbGbCtD
Imiquimod—CYP3A4—Abiraterone—prostate cancer	0.0246	0.0602	CbGbCtD
Imiquimod—CYP1A2—Conjugated Estrogens—prostate cancer	0.0222	0.0543	CbGbCtD
Imiquimod—CYP1A2—Estradiol—prostate cancer	0.0195	0.0477	CbGbCtD
Imiquimod—CYP3A4—Cabazitaxel—prostate cancer	0.0182	0.0445	CbGbCtD
Imiquimod—CYP3A4—Estrone—prostate cancer	0.0178	0.0435	CbGbCtD
Imiquimod—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0159	0.0388	CbGbCtD
Imiquimod—CYP1A2—Etoposide—prostate cancer	0.0127	0.0311	CbGbCtD
Imiquimod—CYP3A4—Conjugated Estrogens—prostate cancer	0.0116	0.0285	CbGbCtD
Imiquimod—CYP3A4—Mitoxantrone—prostate cancer	0.0106	0.0259	CbGbCtD
Imiquimod—CYP3A4—Estradiol—prostate cancer	0.0102	0.025	CbGbCtD
Imiquimod—CYP3A4—Prednisone—prostate cancer	0.00879	0.0215	CbGbCtD
Imiquimod—TLR7—prostate gland—prostate cancer	0.00718	0.24	CbGeAlD
Imiquimod—CYP3A4—Etoposide—prostate cancer	0.00667	0.0163	CbGbCtD
Imiquimod—CYP3A4—Docetaxel—prostate cancer	0.00611	0.0149	CbGbCtD
Imiquimod—TLR8—bone marrow—prostate cancer	0.00587	0.196	CbGeAlD
Imiquimod—CYP3A4—Doxorubicin—prostate cancer	0.00455	0.0111	CbGbCtD
Imiquimod—TLR8—lymph node—prostate cancer	0.00363	0.122	CbGeAlD
Imiquimod—CYP1A2—urine—prostate cancer	0.0036	0.121	CbGeAlD
Imiquimod—TLR7—testis—prostate cancer	0.00316	0.106	CbGeAlD
Imiquimod—CYP3A4—urine—prostate cancer	0.00261	0.0873	CbGeAlD
Imiquimod—TLR7—lymph node—prostate cancer	0.00229	0.0768	CbGeAlD
Imiquimod—CYP1A2—renal system—prostate cancer	0.000881	0.0295	CbGeAlD
Imiquimod—CYP3A4—renal system—prostate cancer	0.000638	0.0214	CbGeAlD
Imiquimod—Conjunctivitis—Doxorubicin—prostate cancer	4.37e-05	0.000192	CcSEcCtD
Imiquimod—Nervous system disorder—Capecitabine—prostate cancer	4.36e-05	0.000191	CcSEcCtD
Imiquimod—Haemorrhage—Epirubicin—prostate cancer	4.36e-05	0.000191	CcSEcCtD
Imiquimod—Syncope—Prednisone—prostate cancer	4.35e-05	0.000191	CcSEcCtD
Imiquimod—Tachycardia—Capecitabine—prostate cancer	4.34e-05	0.00019	CcSEcCtD
Imiquimod—Pharyngitis—Epirubicin—prostate cancer	4.33e-05	0.00019	CcSEcCtD
Imiquimod—Skin disorder—Capecitabine—prostate cancer	4.32e-05	0.000189	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—prostate cancer	4.31e-05	0.000189	CcSEcCtD
Imiquimod—Hyperhidrosis—Capecitabine—prostate cancer	4.3e-05	0.000189	CcSEcCtD
Imiquimod—Connective tissue disorder—Epirubicin—prostate cancer	4.29e-05	0.000188	CcSEcCtD
Imiquimod—Urethral disorder—Epirubicin—prostate cancer	4.27e-05	0.000187	CcSEcCtD
Imiquimod—Loss of consciousness—Prednisone—prostate cancer	4.27e-05	0.000187	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—prostate cancer	4.25e-05	0.000186	CcSEcCtD
Imiquimod—Anorexia—Capecitabine—prostate cancer	4.24e-05	0.000186	CcSEcCtD
Imiquimod—Nausea—Estradiol—prostate cancer	4.24e-05	0.000186	CcSEcCtD
Imiquimod—Vomiting—Mitoxantrone—prostate cancer	4.23e-05	0.000185	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—prostate cancer	4.22e-05	0.000185	CcSEcCtD
Imiquimod—Convulsion—Prednisone—prostate cancer	4.21e-05	0.000184	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—prostate cancer	4.2e-05	0.000184	CcSEcCtD
Imiquimod—Hypertension—Prednisone—prostate cancer	4.19e-05	0.000184	CcSEcCtD
Imiquimod—Rash—Mitoxantrone—prostate cancer	4.19e-05	0.000184	CcSEcCtD
Imiquimod—Dermatitis—Mitoxantrone—prostate cancer	4.19e-05	0.000184	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.19e-05	0.000183	CcSEcCtD
Imiquimod—Headache—Mitoxantrone—prostate cancer	4.16e-05	0.000183	CcSEcCtD
Imiquimod—Insomnia—Docetaxel—prostate cancer	4.15e-05	0.000182	CcSEcCtD
Imiquimod—Arthralgia—Prednisone—prostate cancer	4.13e-05	0.000181	CcSEcCtD
Imiquimod—Myalgia—Prednisone—prostate cancer	4.13e-05	0.000181	CcSEcCtD
Imiquimod—Paraesthesia—Docetaxel—prostate cancer	4.12e-05	0.000181	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—prostate cancer	4.12e-05	0.000181	CcSEcCtD
Imiquimod—Anxiety—Prednisone—prostate cancer	4.12e-05	0.000181	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.1e-05	0.00018	CcSEcCtD
Imiquimod—Dyspnoea—Docetaxel—prostate cancer	4.1e-05	0.00018	CcSEcCtD
Imiquimod—Somnolence—Docetaxel—prostate cancer	4.08e-05	0.000179	CcSEcCtD
Imiquimod—Discomfort—Prednisone—prostate cancer	4.08e-05	0.000179	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—prostate cancer	4.08e-05	0.000179	CcSEcCtD
Imiquimod—Hypersensitivity—Etoposide—prostate cancer	4.07e-05	0.000179	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—prostate cancer	4.07e-05	0.000178	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—prostate cancer	4.06e-05	0.000178	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.05e-05	0.000178	CcSEcCtD
Imiquimod—Flushing—Epirubicin—prostate cancer	4.05e-05	0.000177	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—prostate cancer	4.05e-05	0.000177	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—prostate cancer	4.04e-05	0.000177	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—prostate cancer	4.04e-05	0.000177	CcSEcCtD
Imiquimod—Insomnia—Capecitabine—prostate cancer	4.02e-05	0.000176	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—prostate cancer	4e-05	0.000176	CcSEcCtD
Imiquimod—Paraesthesia—Capecitabine—prostate cancer	3.99e-05	0.000175	CcSEcCtD
Imiquimod—Decreased appetite—Docetaxel—prostate cancer	3.99e-05	0.000175	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—prostate cancer	3.98e-05	0.000175	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Docetaxel—prostate cancer	3.97e-05	0.000174	CcSEcCtD
Imiquimod—Asthenia—Etoposide—prostate cancer	3.97e-05	0.000174	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—prostate cancer	3.97e-05	0.000174	CcSEcCtD
Imiquimod—Dyspnoea—Capecitabine—prostate cancer	3.97e-05	0.000174	CcSEcCtD
Imiquimod—Oedema—Prednisone—prostate cancer	3.96e-05	0.000174	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—prostate cancer	3.96e-05	0.000174	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—prostate cancer	3.96e-05	0.000173	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—prostate cancer	3.96e-05	0.000173	CcSEcCtD
Imiquimod—Nausea—Mitoxantrone—prostate cancer	3.95e-05	0.000173	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—prostate cancer	3.94e-05	0.000173	CcSEcCtD
Imiquimod—Infection—Prednisone—prostate cancer	3.94e-05	0.000173	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—prostate cancer	3.93e-05	0.000172	CcSEcCtD
Imiquimod—Pain—Docetaxel—prostate cancer	3.93e-05	0.000172	CcSEcCtD
Imiquimod—Dyspepsia—Capecitabine—prostate cancer	3.91e-05	0.000172	CcSEcCtD
Imiquimod—Chills—Epirubicin—prostate cancer	3.91e-05	0.000172	CcSEcCtD
Imiquimod—Pruritus—Etoposide—prostate cancer	3.91e-05	0.000171	CcSEcCtD
Imiquimod—Shock—Prednisone—prostate cancer	3.9e-05	0.000171	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—prostate cancer	3.9e-05	0.000171	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—prostate cancer	3.89e-05	0.00017	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—prostate cancer	3.88e-05	0.00017	CcSEcCtD
Imiquimod—Tachycardia—Prednisone—prostate cancer	3.87e-05	0.00017	CcSEcCtD
Imiquimod—Decreased appetite—Capecitabine—prostate cancer	3.87e-05	0.00017	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—prostate cancer	3.85e-05	0.000169	CcSEcCtD
Imiquimod—Skin disorder—Prednisone—prostate cancer	3.85e-05	0.000169	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Capecitabine—prostate cancer	3.84e-05	0.000168	CcSEcCtD
Imiquimod—Fatigue—Capecitabine—prostate cancer	3.83e-05	0.000168	CcSEcCtD
Imiquimod—Hyperhidrosis—Prednisone—prostate cancer	3.83e-05	0.000168	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—prostate cancer	3.82e-05	0.000168	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—prostate cancer	3.82e-05	0.000167	CcSEcCtD
Imiquimod—Pain—Capecitabine—prostate cancer	3.8e-05	0.000167	CcSEcCtD
Imiquimod—Erythema—Epirubicin—prostate cancer	3.8e-05	0.000166	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—prostate cancer	3.8e-05	0.000166	CcSEcCtD
Imiquimod—Feeling abnormal—Docetaxel—prostate cancer	3.79e-05	0.000166	CcSEcCtD
Imiquimod—Diarrhoea—Etoposide—prostate cancer	3.78e-05	0.000166	CcSEcCtD
Imiquimod—Anorexia—Prednisone—prostate cancer	3.78e-05	0.000166	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—prostate cancer	3.77e-05	0.000165	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—prostate cancer	3.76e-05	0.000165	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—prostate cancer	3.76e-05	0.000165	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—prostate cancer	3.74e-05	0.000164	CcSEcCtD
Imiquimod—Back pain—Epirubicin—prostate cancer	3.67e-05	0.000161	CcSEcCtD
Imiquimod—Feeling abnormal—Capecitabine—prostate cancer	3.66e-05	0.000161	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—prostate cancer	3.66e-05	0.000161	CcSEcCtD
Imiquimod—Dizziness—Etoposide—prostate cancer	3.66e-05	0.00016	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—prostate cancer	3.64e-05	0.00016	CcSEcCtD
Imiquimod—Gastrointestinal pain—Capecitabine—prostate cancer	3.64e-05	0.000159	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—prostate cancer	3.64e-05	0.000159	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—prostate cancer	3.63e-05	0.000159	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—prostate cancer	3.63e-05	0.000159	CcSEcCtD
Imiquimod—Chills—Doxorubicin—prostate cancer	3.62e-05	0.000159	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Prednisone—prostate cancer	3.61e-05	0.000158	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—prostate cancer	3.6e-05	0.000158	CcSEcCtD
Imiquimod—Insomnia—Prednisone—prostate cancer	3.58e-05	0.000157	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—prostate cancer	3.57e-05	0.000156	CcSEcCtD
Imiquimod—Paraesthesia—Prednisone—prostate cancer	3.56e-05	0.000156	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—prostate cancer	3.54e-05	0.000155	CcSEcCtD
Imiquimod—Urticaria—Capecitabine—prostate cancer	3.53e-05	0.000155	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—prostate cancer	3.52e-05	0.000154	CcSEcCtD
Imiquimod—Abdominal pain—Capecitabine—prostate cancer	3.52e-05	0.000154	CcSEcCtD
Imiquimod—Body temperature increased—Capecitabine—prostate cancer	3.52e-05	0.000154	CcSEcCtD
Imiquimod—Vomiting—Etoposide—prostate cancer	3.51e-05	0.000154	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—prostate cancer	3.51e-05	0.000154	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—prostate cancer	3.51e-05	0.000154	CcSEcCtD
Imiquimod—Agitation—Epirubicin—prostate cancer	3.49e-05	0.000153	CcSEcCtD
Imiquimod—Dyspepsia—Prednisone—prostate cancer	3.49e-05	0.000153	CcSEcCtD
Imiquimod—Rash—Etoposide—prostate cancer	3.49e-05	0.000153	CcSEcCtD
Imiquimod—Dermatitis—Etoposide—prostate cancer	3.48e-05	0.000153	CcSEcCtD
Imiquimod—Headache—Etoposide—prostate cancer	3.46e-05	0.000152	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—prostate cancer	3.44e-05	0.000151	CcSEcCtD
Imiquimod—Malaise—Epirubicin—prostate cancer	3.42e-05	0.00015	CcSEcCtD
Imiquimod—Fatigue—Prednisone—prostate cancer	3.42e-05	0.00015	CcSEcCtD
Imiquimod—Syncope—Epirubicin—prostate cancer	3.4e-05	0.000149	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—prostate cancer	3.4e-05	0.000149	CcSEcCtD
Imiquimod—Hypersensitivity—Docetaxel—prostate cancer	3.38e-05	0.000148	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—prostate cancer	3.35e-05	0.000147	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—prostate cancer	3.34e-05	0.000146	CcSEcCtD
Imiquimod—Cough—Epirubicin—prostate cancer	3.31e-05	0.000145	CcSEcCtD
Imiquimod—Asthenia—Docetaxel—prostate cancer	3.3e-05	0.000145	CcSEcCtD
Imiquimod—Convulsion—Epirubicin—prostate cancer	3.29e-05	0.000144	CcSEcCtD
Imiquimod—Nausea—Etoposide—prostate cancer	3.28e-05	0.000144	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—prostate cancer	3.28e-05	0.000144	CcSEcCtD
Imiquimod—Hypersensitivity—Capecitabine—prostate cancer	3.28e-05	0.000144	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisone—prostate cancer	3.26e-05	0.000143	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—prostate cancer	3.26e-05	0.000143	CcSEcCtD
Imiquimod—Pruritus—Docetaxel—prostate cancer	3.25e-05	0.000142	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—prostate cancer	3.24e-05	0.000142	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—prostate cancer	3.23e-05	0.000142	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—prostate cancer	3.23e-05	0.000142	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—prostate cancer	3.23e-05	0.000142	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—prostate cancer	3.23e-05	0.000142	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—prostate cancer	3.22e-05	0.000141	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.21e-05	0.000141	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—prostate cancer	3.19e-05	0.00014	CcSEcCtD
Imiquimod—Asthenia—Capecitabine—prostate cancer	3.19e-05	0.00014	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—prostate cancer	3.17e-05	0.000139	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—prostate cancer	3.16e-05	0.000139	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—prostate cancer	3.15e-05	0.000138	CcSEcCtD
Imiquimod—Urticaria—Prednisone—prostate cancer	3.15e-05	0.000138	CcSEcCtD
Imiquimod—Pruritus—Capecitabine—prostate cancer	3.15e-05	0.000138	CcSEcCtD
Imiquimod—Diarrhoea—Docetaxel—prostate cancer	3.14e-05	0.000138	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—prostate cancer	3.13e-05	0.000137	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—prostate cancer	3.13e-05	0.000137	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—prostate cancer	3.1e-05	0.000136	CcSEcCtD
Imiquimod—Oedema—Epirubicin—prostate cancer	3.1e-05	0.000136	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—prostate cancer	3.09e-05	0.000135	CcSEcCtD
Imiquimod—Infection—Epirubicin—prostate cancer	3.08e-05	0.000135	CcSEcCtD
Imiquimod—Cough—Doxorubicin—prostate cancer	3.07e-05	0.000134	CcSEcCtD
Imiquimod—Shock—Epirubicin—prostate cancer	3.05e-05	0.000134	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—prostate cancer	3.04e-05	0.000133	CcSEcCtD
Imiquimod—Diarrhoea—Capecitabine—prostate cancer	3.04e-05	0.000133	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—prostate cancer	3.04e-05	0.000133	CcSEcCtD
Imiquimod—Dizziness—Docetaxel—prostate cancer	3.04e-05	0.000133	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—prostate cancer	3.03e-05	0.000133	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—prostate cancer	3.02e-05	0.000133	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—prostate cancer	3.01e-05	0.000132	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—prostate cancer	3e-05	0.000131	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—prostate cancer	2.99e-05	0.000131	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—prostate cancer	2.99e-05	0.000131	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—prostate cancer	2.99e-05	0.000131	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—prostate cancer	2.98e-05	0.000131	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.97e-05	0.00013	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—prostate cancer	2.95e-05	0.00013	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—prostate cancer	2.95e-05	0.000129	CcSEcCtD
Imiquimod—Dizziness—Capecitabine—prostate cancer	2.94e-05	0.000129	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—prostate cancer	2.92e-05	0.000128	CcSEcCtD
Imiquimod—Vomiting—Docetaxel—prostate cancer	2.92e-05	0.000128	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisone—prostate cancer	2.92e-05	0.000128	CcSEcCtD
Imiquimod—Rash—Docetaxel—prostate cancer	2.9e-05	0.000127	CcSEcCtD
Imiquimod—Dermatitis—Docetaxel—prostate cancer	2.89e-05	0.000127	CcSEcCtD
Imiquimod—Headache—Docetaxel—prostate cancer	2.88e-05	0.000126	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—prostate cancer	2.87e-05	0.000126	CcSEcCtD
Imiquimod—Infection—Doxorubicin—prostate cancer	2.85e-05	0.000125	CcSEcCtD
Imiquimod—Asthenia—Prednisone—prostate cancer	2.84e-05	0.000125	CcSEcCtD
Imiquimod—Vomiting—Capecitabine—prostate cancer	2.83e-05	0.000124	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.82e-05	0.000124	CcSEcCtD
Imiquimod—Shock—Doxorubicin—prostate cancer	2.82e-05	0.000124	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—prostate cancer	2.81e-05	0.000123	CcSEcCtD
Imiquimod—Rash—Capecitabine—prostate cancer	2.8e-05	0.000123	CcSEcCtD
Imiquimod—Pruritus—Prednisone—prostate cancer	2.8e-05	0.000123	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—prostate cancer	2.8e-05	0.000123	CcSEcCtD
Imiquimod—Dermatitis—Capecitabine—prostate cancer	2.8e-05	0.000123	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—prostate cancer	2.8e-05	0.000123	CcSEcCtD
Imiquimod—Headache—Capecitabine—prostate cancer	2.79e-05	0.000122	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—prostate cancer	2.78e-05	0.000122	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—prostate cancer	2.78e-05	0.000122	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—prostate cancer	2.77e-05	0.000122	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—prostate cancer	2.76e-05	0.000121	CcSEcCtD
Imiquimod—Somnolence—Epirubicin—prostate cancer	2.75e-05	0.000121	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Imiquimod—Nausea—Docetaxel—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—prostate cancer	2.73e-05	0.00012	CcSEcCtD
Imiquimod—Diarrhoea—Prednisone—prostate cancer	2.71e-05	0.000119	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—prostate cancer	2.69e-05	0.000118	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—prostate cancer	2.67e-05	0.000117	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—prostate cancer	2.67e-05	0.000117	CcSEcCtD
Imiquimod—Pain—Epirubicin—prostate cancer	2.65e-05	0.000116	CcSEcCtD
Imiquimod—Nausea—Capecitabine—prostate cancer	2.64e-05	0.000116	CcSEcCtD
Imiquimod—Dizziness—Prednisone—prostate cancer	2.62e-05	0.000115	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.61e-05	0.000115	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—prostate cancer	2.59e-05	0.000114	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—prostate cancer	2.57e-05	0.000113	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—prostate cancer	2.56e-05	0.000112	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—prostate cancer	2.55e-05	0.000112	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—prostate cancer	2.55e-05	0.000112	CcSEcCtD
Imiquimod—Gastrointestinal pain—Epirubicin—prostate cancer	2.53e-05	0.000111	CcSEcCtD
Imiquimod—Dyspepsia—Doxorubicin—prostate cancer	2.52e-05	0.000111	CcSEcCtD
Imiquimod—Vomiting—Prednisone—prostate cancer	2.52e-05	0.00011	CcSEcCtD
Imiquimod—Rash—Prednisone—prostate cancer	2.5e-05	0.00011	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—prostate cancer	2.5e-05	0.000109	CcSEcCtD
Imiquimod—Decreased appetite—Doxorubicin—prostate cancer	2.49e-05	0.000109	CcSEcCtD
Imiquimod—Headache—Prednisone—prostate cancer	2.48e-05	0.000109	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.48e-05	0.000109	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—prostate cancer	2.47e-05	0.000108	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—prostate cancer	2.46e-05	0.000108	CcSEcCtD
Imiquimod—Pain—Doxorubicin—prostate cancer	2.45e-05	0.000107	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—prostate cancer	2.45e-05	0.000107	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—prostate cancer	2.45e-05	0.000107	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—prostate cancer	2.36e-05	0.000104	CcSEcCtD
Imiquimod—Nausea—Prednisone—prostate cancer	2.35e-05	0.000103	CcSEcCtD
Imiquimod—Gastrointestinal pain—Doxorubicin—prostate cancer	2.34e-05	0.000103	CcSEcCtD
Imiquimod—Hypersensitivity—Epirubicin—prostate cancer	2.28e-05	0.0001	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—prostate cancer	2.28e-05	9.99e-05	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—prostate cancer	2.27e-05	9.94e-05	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—prostate cancer	2.27e-05	9.94e-05	CcSEcCtD
Imiquimod—Asthenia—Epirubicin—prostate cancer	2.22e-05	9.75e-05	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—prostate cancer	2.19e-05	9.61e-05	CcSEcCtD
Imiquimod—Diarrhoea—Epirubicin—prostate cancer	2.12e-05	9.29e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—prostate cancer	2.11e-05	9.26e-05	CcSEcCtD
Imiquimod—Asthenia—Doxorubicin—prostate cancer	2.06e-05	9.02e-05	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—prostate cancer	2.05e-05	8.98e-05	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—prostate cancer	2.03e-05	8.89e-05	CcSEcCtD
Imiquimod—Vomiting—Epirubicin—prostate cancer	1.97e-05	8.64e-05	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—prostate cancer	1.96e-05	8.6e-05	CcSEcCtD
Imiquimod—Rash—Epirubicin—prostate cancer	1.95e-05	8.57e-05	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—prostate cancer	1.95e-05	8.56e-05	CcSEcCtD
Imiquimod—Headache—Epirubicin—prostate cancer	1.94e-05	8.51e-05	CcSEcCtD
Imiquimod—Dizziness—Doxorubicin—prostate cancer	1.9e-05	8.31e-05	CcSEcCtD
Imiquimod—Nausea—Epirubicin—prostate cancer	1.84e-05	8.07e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	1.84e-05	0.000137	CbGpPWpGaD
Imiquimod—Vomiting—Doxorubicin—prostate cancer	1.82e-05	7.99e-05	CcSEcCtD
Imiquimod—Rash—Doxorubicin—prostate cancer	1.81e-05	7.93e-05	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—prostate cancer	1.81e-05	7.92e-05	CcSEcCtD
Imiquimod—Headache—Doxorubicin—prostate cancer	1.8e-05	7.87e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—COMT—prostate cancer	1.78e-05	0.000132	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTP1—prostate cancer	1.77e-05	0.000132	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	1.76e-05	0.000131	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	1.75e-05	0.00013	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KRAS—prostate cancer	1.75e-05	0.00013	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	1.74e-05	0.00013	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—prostate cancer	1.73e-05	0.000129	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—prostate cancer	1.7e-05	7.47e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	1.69e-05	0.000126	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	1.64e-05	0.000122	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.62e-05	0.000121	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GRHL1—prostate cancer	1.61e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADI1—prostate cancer	1.61e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CBR1—prostate cancer	1.61e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PSAT1—prostate cancer	1.61e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TST—prostate cancer	1.61e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CSAD—prostate cancer	1.61e-05	0.000119	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CA—prostate cancer	1.6e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.6e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.57e-05	0.000117	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.54e-05	0.000115	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.54e-05	0.000114	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HAO1—prostate cancer	1.52e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.52e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UGT2B15—prostate cancer	1.49e-05	0.000111	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UGT2B17—prostate cancer	1.49e-05	0.000111	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CKMT2—prostate cancer	1.49e-05	0.000111	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GRHPR—prostate cancer	1.49e-05	0.000111	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.46e-05	0.000109	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.44e-05	0.000107	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—prostate cancer	1.42e-05	0.000106	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AOX1—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SULT2B1—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MBTPS1—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAGLU—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RFK—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM3—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PGAM2—prostate cancer	1.4e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.37e-05	0.000102	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AMACR—prostate cancer	1.33e-05	9.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP3A43—prostate cancer	1.33e-05	9.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAT1—prostate cancer	1.33e-05	9.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SRD5A2—prostate cancer	1.33e-05	9.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DEGS1—prostate cancer	1.33e-05	9.9e-05	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—prostate cancer	1.31e-05	9.74e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.31e-05	9.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.3e-05	9.67e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD17B1—prostate cancer	1.27e-05	9.44e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.27e-05	9.44e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PSAT1—prostate cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CBR1—prostate cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TST—prostate cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CSAD—prostate cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADI1—prostate cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GRHL1—prostate cancer	1.24e-05	9.22e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.22e-05	9.08e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.21e-05	9.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.2e-05	8.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.15e-05	8.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CKMT2—prostate cancer	1.15e-05	8.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GRHPR—prostate cancer	1.15e-05	8.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.15e-05	8.57e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.14e-05	8.51e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—B4GALT4—prostate cancer	1.13e-05	8.41e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HPGD—prostate cancer	1.13e-05	8.41e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PGAM2—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AOX1—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAGLU—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RFK—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM3—prostate cancer	1.08e-05	8.06e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.06e-05	7.91e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTAP—prostate cancer	1.03e-05	7.7e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.03e-05	7.7e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.03e-05	7.64e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AMACR—prostate cancer	1.03e-05	7.64e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.03e-05	7.64e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DEGS1—prostate cancer	1.03e-05	7.64e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAT1—prostate cancer	1.03e-05	7.64e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.01e-05	7.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.01e-05	7.5e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.01e-05	7.5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.8e-06	7.29e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.79e-06	7.28e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.65e-06	7.18e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACSL4—prostate cancer	9.62e-06	7.15e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD17B3—prostate cancer	9.62e-06	7.15e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.51e-06	7.07e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UMPS—prostate cancer	9.22e-06	6.86e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ARG2—prostate cancer	9.22e-06	6.86e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PHGDH—prostate cancer	9.22e-06	6.86e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	9.18e-06	6.82e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LDHB—prostate cancer	9.04e-06	6.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP3A5—prostate cancer	8.88e-06	6.6e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.73e-06	6.49e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HPGD—prostate cancer	8.73e-06	6.49e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA3—prostate cancer	8.57e-06	6.38e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TCN2—prostate cancer	8.57e-06	6.38e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UCP3—prostate cancer	8.57e-06	6.38e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PDHA1—prostate cancer	8.57e-06	6.38e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.21e-06	6.11e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC22A3—prostate cancer	8.18e-06	6.08e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD3B1—prostate cancer	8.18e-06	6.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTAP—prostate cancer	7.99e-06	5.94e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.99e-06	5.94e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.94e-06	5.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA4—prostate cancer	7.84e-06	5.83e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TBXAS1—prostate cancer	7.84e-06	5.83e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.78e-06	5.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.78e-06	5.79e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.66e-06	5.7e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA2—prostate cancer	7.64e-06	5.68e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG5—prostate cancer	7.55e-06	5.61e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SULT1A1—prostate cancer	7.55e-06	5.61e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACSL4—prostate cancer	7.42e-06	5.52e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.42e-06	5.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA1—prostate cancer	7.37e-06	5.48e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAT2—prostate cancer	7.29e-06	5.42e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD3B2—prostate cancer	7.29e-06	5.42e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTO1—prostate cancer	7.29e-06	5.42e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ARG2—prostate cancer	7.12e-06	5.29e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UMPS—prostate cancer	7.12e-06	5.29e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PHGDH—prostate cancer	7.12e-06	5.29e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.01e-06	5.21e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLCB2—prostate cancer	6.99e-06	5.2e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LRP2—prostate cancer	6.99e-06	5.2e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.99e-06	5.2e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LDHB—prostate cancer	6.98e-06	5.19e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—P4HB—prostate cancer	6.85e-06	5.1e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.85e-06	5.1e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC22A1—prostate cancer	6.67e-06	4.96e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TCN2—prostate cancer	6.62e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UCP3—prostate cancer	6.62e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PDHA1—prostate cancer	6.62e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA3—prostate cancer	6.62e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.59e-06	4.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SULT2A1—prostate cancer	6.5e-06	4.83e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MED12—prostate cancer	6.39e-06	4.75e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GNG5—prostate cancer	6.34e-06	4.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.31e-06	4.69e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.31e-06	4.69e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA3—prostate cancer	6.11e-06	4.54e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA4—prostate cancer	6.05e-06	4.5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TBXAS1—prostate cancer	6.05e-06	4.5e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6e-06	4.46e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA2—prostate cancer	5.9e-06	4.39e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HPGDS—prostate cancer	5.83e-06	4.33e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.83e-06	4.33e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG5—prostate cancer	5.83e-06	4.33e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.79e-06	4.31e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA1—prostate cancer	5.69e-06	4.23e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACHE—prostate cancer	5.65e-06	4.2e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTT1—prostate cancer	5.65e-06	4.2e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.63e-06	4.18e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAT2—prostate cancer	5.63e-06	4.18e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTO1—prostate cancer	5.63e-06	4.18e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2A6—prostate cancer	5.59e-06	4.16e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.57e-06	4.14e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKR1C3—prostate cancer	5.44e-06	4.04e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PRKACB—prostate cancer	5.41e-06	4.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLCB2—prostate cancer	5.39e-06	4.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.39e-06	4.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LRP2—prostate cancer	5.39e-06	4.01e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP17A1—prostate cancer	5.35e-06	3.98e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—P4HB—prostate cancer	5.29e-06	3.93e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.28e-06	3.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.15e-06	3.83e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA2—prostate cancer	5.1e-06	3.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.01e-06	3.73e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MED12—prostate cancer	4.93e-06	3.67e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GNG5—prostate cancer	4.89e-06	3.64e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.86e-06	3.62e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.75e-06	3.53e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA3—prostate cancer	4.71e-06	3.51e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NQO1—prostate cancer	4.7e-06	3.49e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TH—prostate cancer	4.63e-06	3.44e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.6e-06	3.42e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.58e-06	3.41e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.56e-06	3.39e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.5e-06	3.35e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HPGDS—prostate cancer	4.5e-06	3.35e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.47e-06	3.32e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACHE—prostate cancer	4.36e-06	3.24e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTT1—prostate cancer	4.36e-06	3.24e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GGT1—prostate cancer	4.36e-06	3.24e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.31e-06	3.21e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA1—prostate cancer	4.3e-06	3.2e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.23e-06	3.15e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.19e-06	3.12e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PRKACB—prostate cancer	4.17e-06	3.1e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.13e-06	3.07e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RXRA—prostate cancer	4.09e-06	3.04e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.97e-06	2.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—COMT—prostate cancer	3.94e-06	2.93e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA2—prostate cancer	3.93e-06	2.93e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTP1—prostate cancer	3.92e-06	2.91e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ITPR1—prostate cancer	3.86e-06	2.87e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.79e-06	2.82e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.75e-06	2.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.67e-06	2.73e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMS—prostate cancer	3.64e-06	2.71e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NQO1—prostate cancer	3.63e-06	2.7e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—prostate cancer	3.6e-06	2.68e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TH—prostate cancer	3.57e-06	2.66e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPL—prostate cancer	3.53e-06	2.63e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.48e-06	2.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.41e-06	2.54e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ERCC2—prostate cancer	3.39e-06	2.52e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GGT1—prostate cancer	3.37e-06	2.5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA1—prostate cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.27e-06	2.43e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—prostate cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RXRA—prostate cancer	3.15e-06	2.35e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARA—prostate cancer	3.12e-06	2.32e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—COMT—prostate cancer	3.04e-06	2.26e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTP1—prostate cancer	3.02e-06	2.25e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ITPR1—prostate cancer	2.98e-06	2.21e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—prostate cancer	2.93e-06	2.18e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMS—prostate cancer	2.81e-06	2.09e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.8e-06	2.09e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—prostate cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPL—prostate cancer	2.73e-06	2.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.63e-06	1.96e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ERCC2—prostate cancer	2.61e-06	1.94e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—prostate cancer	2.53e-06	1.88e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CREBBP—prostate cancer	2.48e-06	1.84e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—prostate cancer	2.46e-06	1.83e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARA—prostate cancer	2.41e-06	1.79e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—prostate cancer	2.27e-06	1.68e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—prostate cancer	2.22e-06	1.65e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.06e-06	1.53e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.05e-06	1.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—prostate cancer	2.03e-06	1.51e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—prostate cancer	1.95e-06	1.45e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CREBBP—prostate cancer	1.91e-06	1.42e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.81e-06	1.35e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—prostate cancer	1.77e-06	1.32e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—prostate cancer	1.71e-06	1.27e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—EP300—prostate cancer	1.69e-06	1.26e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.58e-06	1.18e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—prostate cancer	1.57e-06	1.17e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—prostate cancer	1.37e-06	1.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—EP300—prostate cancer	1.3e-06	9.69e-06	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.25e-06	9.29e-06	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—prostate cancer	1.02e-06	7.59e-06	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.64e-07	7.17e-06	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—prostate cancer	7.87e-07	5.86e-06	CbGpPWpGaD
